The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 05, 2023

Filed:

Oct. 07, 2021
Applicant:

Aria Cv, Inc., St. Paul, MN (US);

Inventors:

Karl Vollmers, Minneapolis, MN (US);

Lynn Zwiers, Lino Lakes, CA (US);

John Gainor, Mendota Heights, MN (US);

John Scandurra, Saint Paul, MN (US);

Assignee:

Aria CV, Inc., St. Paul, MN (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 60/869 (2021.01); A61M 60/268 (2021.01); A61M 60/122 (2021.01); A61M 60/135 (2021.01); A61M 60/00 (2021.01); A61M 60/274 (2021.01); A61B 17/12 (2006.01); A61M 1/00 (2006.01); A61M 29/02 (2006.01); C01B 17/00 (2006.01); C01B 17/45 (2006.01); A61B 17/00 (2006.01);
U.S. Cl.
CPC ...
A61M 60/869 (2021.01); A61B 17/12022 (2013.01); A61B 17/12027 (2013.01); A61B 17/12036 (2013.01); A61B 17/12109 (2013.01); A61B 17/12131 (2013.01); A61B 17/12136 (2013.01); A61M 1/00 (2013.01); A61M 29/02 (2013.01); A61M 60/00 (2021.01); A61M 60/122 (2021.01); A61M 60/135 (2021.01); A61M 60/268 (2021.01); A61M 60/274 (2021.01); C01B 17/00 (2013.01); C01B 17/45 (2013.01); C01B 17/453 (2013.01); C01B 17/4507 (2013.01); C01B 17/4515 (2013.01); A61B 2017/00535 (2013.01); A61B 2017/00557 (2013.01); A61M 2202/025 (2013.01); A61M 2202/0208 (2013.01); A61M 2202/0225 (2013.01); A61M 2202/04 (2013.01);
Abstract

Diffusion and infusion resistant implantable devices and methods for reducing pulsatile pressure are provided. The implantable device includes a balloon implantable within a blood vessel of a patient, e.g., the pulmonary artery. The balloon is injected with a fluid mixture comprising a constituent fluid(s) and a diffusion-resistant gas to provide optimal balloon volume and limit fluid diffusion throughout multiple cardiac cycles. The fluid mixture may be pressurized such that the balloon is transitionable between an expanded state and a collapsed state responsive to pressure fluctuations in the blood vessel.


Find Patent Forward Citations

Loading…